GlobeNewswire 2020-07-20 Major Shareholder Announcement

GlobeNewswire 2020-07-16 Genmab Announces Net Sales of DARZALEX® for the Second Quarter of 2020

GlobeNewswire 2020-07-07 Major Shareholder Announcement

GlobeNewswire 2020-07-03 Major Shareholder Announcement

GlobeNewswire 2020-06-29 Genmab Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in ...

GlobeNewswire 2020-06-10 Genmab and AbbVie Announce Broad Oncology Collaboration

GlobeNewswire 2020-06-04 Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (dar...

GlobeNewswire 2020-05-28 Genmab Announces Positive Topline Results in Phase III ANDROMEDA Study of Daratumumab in Light-chain...

GlobeNewswire 2020-05-14 Genmab Announces Data to be Presented at the EHA25 Virtual Congress

GlobeNewswire 2020-05-06 Genmab Announces Financial Results for the First Quarter of 2020

GlobeNewswire 2020-05-01 Genmab Announces U.S. FDA Approval of Subcutaneous Formulation of Daratumumab, DARZALEX FASPRO™ (dar...

GlobeNewswire 2020-04-30 CHMP Issues Positive Opinion Recommending Subcutaneous Formulation of Daratumumab for the Treatment ...

GlobeNewswire 2020-04-14 Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2020

GlobeNewswire 2020-03-10 Genmab Announces Appointment of Anthony Mancini to Newly Created Position of Chief Operating Officer

GlobeNewswire 2020-02-21 Genmab Board of Directors Chairman to Step Down

GlobeNewswire 2020-02-19 Genmab Publishes 2019 Annual Report

GlobeNewswire 2020-01-22 Genmab Announces 2019 Net Sales Figures for DARZALEX® (daratumumab) and Achievement of USD 150 Milli...

GlobeNewswire 2020-01-20 Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bo...

GlobeNewswire 2019-12-19 Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics

GlobeNewswire 2019-12-13 CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Bortezomib, Th...

GlobeNewswire 2019-12-05 Genmab Achieves USD 100 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Jansse...

GlobeNewswire 2019-11-19 Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Le...

GlobeNewswire 2019-11-06 Genmab Announces Financial Results for the First Nine Months of 2019

GlobeNewswire 2019-10-30 David Eatwell to Retire as Chief Financial Officer of Genmab